Literature DB >> 9403027

Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China.

M Yang1, H Zhou, R Y Kong, W F Fong, L Q Ren, X H Liao, Y Wang, W Zhuang, S Yang.   

Abstract

Codon 249 (exon 7) of the putative tumor suppressor gene p53 is a mutational hot-spot for hepatocellular carcinoma (HCC) but not other tumors. DNA samples from primary HCC patients from Tongan, an area of high HCC incidence in China (> 40 per 100,000 population), were analyzed for specific mutations in codon 249 of the p53 gene using polymerase chain reaction (PCR)/restriction-digest methods and direct DNA sequencing. Seven of the 21 samples screened were found to have a point mutation at the third base position of codon 249 (AGG to AGT). The result is consistent with previous reports that the G-->T transversion is positively associated with the level of dietary aflatoxin B1 (AFB1) contamination, which has been implicated as one of the risk factors in Tongan area. Of the 7 HCC patients that contained the codon 249 point mutation, one was hepatitis B virus (HBV)-negative. This is only the second documentation of an HCC patient harboring the p53 codon 249 mutation, who was HBV-negative.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403027     DOI: 10.1016/s0027-5107(97)00142-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Monitoring of mycotoxin biomarkers in the Czech Republic.

Authors:  V Ostry; F Malir; T Roubal; J Skarkova; J Ruprich; M Cerna; E E Creppy
Journal:  Mycotoxin Res       Date:  2005-03       Impact factor: 3.833

2.  Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.

Authors:  Xing-Hua Huang; Lu-Hong Sun; Dong-Dong Lu; Yan Sun; Li-Jie Ma; Xi-Ran Zhang; Jian Huang; Long Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 3.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

Review 4.  Chemistry and structural biology of DNA damage and biological consequences.

Authors:  Michael P Stone; Hai Huang; Kyle L Brown; Ganesh Shanmugam
Journal:  Chem Biodivers       Date:  2011-09       Impact factor: 2.408

5.  The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.

Authors:  Filiz Türe Ozdemir; Arzu Tiftikci; Seda Sancak; Fatih Eren; Veysel Tahan; Hakan Akın; Feyza Gündüz; Ala Eldeen Kedrah; Yücel Ustündağ; Erol Avşar; Nurdan Tözün; Osman Ozdoğan
Journal:  J Gastrointest Cancer       Date:  2010-09

6.  Bypass of aflatoxin B1 adducts by the Sulfolobus solfataricus DNA polymerase IV.

Authors:  Surajit Banerjee; Kyle L Brown; Martin Egli; Michael P Stone
Journal:  J Am Chem Soc       Date:  2011-07-26       Impact factor: 15.419

7.  Structural perturbations induced by the alpha-anomer of the aflatoxin B(1) formamidopyrimidine adduct in duplex and single-strand DNA.

Authors:  Kyle L Brown; Markus W Voehler; Shane M Magee; Constance M Harris; Thomas M Harris; Michael P Stone
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.